Clinical trial
Cisplatin and Radiation Therapy in Treating Patients With Stage IV Cancer of the…
NCT00002932 · Radiation Therapy Oncology Group, Other · Completed
Key facts
| NCT number | NCT00002932 |
|---|---|
| Title | Cisplatin and Radiation Therapy in Treating Patients With Stage IV Cancer of the Head and Neck |
| Official title | Phase II Multi-Institutional Trial of Targeted Supradose Cisplatin Chemoradiation for Stage IV Squamous Cell Carcinoma of the Head and Neck |
| Lead sponsor | Radiation Therapy Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH NRG Oncology |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug, Radiation |
| Interventions | cisplatin, radiation therapy |
| Enrollment | 60 |
| Start date | May 1, 1997 |
| Primary completion | Mar 1, 2001 |
| Completion | Mar 1, 2005 |
| First posted | Sep 3, 2004 |
| Last update posted | Nov 21, 2014 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: